Skip to content

Evaluating the efficacy of transcranial magnetic stimulation to improve the disturbance of consciousness through electrophysiological techniques

Arousal effects of repetitive transcranial magnetic stimulation on coma patients

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030419
Enrollment
Unknown
Registered
2020-03-01
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorders of consciousness

Interventions

TMS group:repetitive transcranial magnetic stimulation
sham TMS group:sham repetitive transcranial magnetic stimulation

Sponsors

The First Affiliated Hospital, Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Disorders of consciousness caused by traumatic and non-traumatic causes; 2. Ages 18 to 80 years; 3. First onset, within 1-6 months; 4. Family members of the patients agreed and signed informed consent for treatment.

Exclusion criteria

Exclusion criteria: 1. Unstable vital signs; 2. Intracranial malignant tumor or unruptured aneurysm; 3. History of seizures or hydrocephalus; 4. Pregnancy; 5. Contraindications to MRI: intracranial metal implantation or installation of pacemaker,etc.; 6. Complicated severe cardiovascular and liver Patients with renal disease; 7. Other contraindications to transcranial magnetic stimulation. 8. History of drug and alcohol addiction; 9. History of sedative use; 10. History of liver and kidney failure.

Design outcomes

Primary

MeasureTime frame
somatosensory evoked potential;Brainstem auditory evoked potential;

Secondary

MeasureTime frame
Glasgow coma scale;Coma recovery scale-revised;Full outline of responsiveness;

Countries

China

Contacts

Public ContactJianmin Chen

The First Affiliated Hospital, Fujian Medical University

339728290@qq.com+86 15806033997

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026